Novel biologic therapies for thymic epithelial tumors (Q33605995)

28 July 2017

title

Novel biologic therapies for thymic epithelial tumors (English)

1 reference

28 July 2017

Anish Thomas

3

0 references

author name string

Yuanbin Chen

series ordinal

1

1 reference

28 July 2017

Helen Gharwan

series ordinal

2

1 reference

28 July 2017

publication date

7 May 2014

1 reference

28 July 2017

published in

Frontiers in Oncology

1 reference

28 July 2017

volume

4

1 reference

28 July 2017

page(s)

103

1 reference

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Optimal therapy for thymoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019864

Somatostatin analogs and prednisone in advanced refractory thymic tumors.

21 June 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Imatinib mesylate in thymic epithelial malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Epidermal growth factor receptor expression in invasive thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00103

Chemotherapy for invasive thymoma. A 13-year experience

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24847446

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24847446

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FONC.2014.00103

1 reference

28 July 2017

1 reference

28 July 2017

1 reference